Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervicothoracic Sympathetic Chain Block for Post COVID Condition (CeASE)
NCT07468604Phase 4Recruiting
- Sponsor
- University Health Network
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in post-COVID-19 condition (PCC), autonomic dysfunction, sponsored by University Health Network. Started May 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
post-COVID-19 condition (PCC)autonomic dysfunction
Beyond the preview
Go deeper on NCT07468604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07468604.